Effects Of Melanocortins On Ingestive Behavior

Handbook of Biologically Active Peptides

Volumn , Issue , 2006, Pages 903-912

  Rene, Patricia ^b   Cone, Roger D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72449126055     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369442-3/50127-6     Document Type: Chapter

References (113)

1. Adam R.A., Kas M.J. Inverse agonism gains weight. Trends Pharmacol Sci 2003, 24(6):315-321.
2. Andersson U., et al. AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 2004, 279(13):12005-12008.
3. Andersson U., et al. Exercise in rats does not alter hypothalamic AMP-activated protein kinase activity. Biochem Biophys Res Commun 2005, 329(2):719-725.
4. Ariyasu H., et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001, 86(10):4753-4758.
5. Azzara A.V., Sokolnicki J.P., Schwartz G.J. Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition. Physiol Behav. 2002, 77(2-3):411-416.
6. Bamshad M., et al. Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. Am. J Physiol 1998, 275(1 pt 2):R291-R299.
7. Benoit S.C., et al. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producting aversive consequences. J Neurosci 2000, 20(9):3442-3448.
8. Biebermann H., et al. Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 2003, 12:2984-2988.
9. Blum M, Roberts J.L., Wardlaw S.L. Androgen regulation of proopiomelanocortin gene expression and peptide content in the basal hypothalamus. Endocrinology 1989, 124:2283-2288.
10. Branson R., et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003, 348(12):1096.
11. Broberger C., et al. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 1998, 95(25):15043-15048.
12. Bruning J.C., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289(5487):2122-2125.
13. Butler A.A., et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000, 141(9):3518-3521.
14. Butler A.A., et al. Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat Neurosci 2001, 4(6):605-611.
15. Chen A.S., et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000, 26(1):97-102.
16. Clement K., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction [see comments]. Nature 1998, 392(6674):398-401.
17. Cowley M.A., et al. Integration of NPY, AGRP, and melano-cortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat. Neuron 1999, 24:155-163.
18. Cowley M.A., et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001, 411(6836):480-484.
19. Cowley M.A., et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic cricuit regulating energy homeostasis. Neuron 2003, 37(4):649-661.
20. Cummings D.E., et al. A preprandial rise in plasma ghrelin levels suggest a role in meal initiation in humans. Diabetes 2001, 50:1714-1719.
21. Daniels D., et al. Melanocortin receptor signaling through mitogen-activated protein kinase in vivo and in rat hypothalamus. Brain Res 2003, 986(1-2):1-11.
22. Date Y., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123(4):1120-1128.
23. Elmquist J.K., et al. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 1997, 138:839-842.
24. Erickson J., Hollopeter G., Palmiter J.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996, 274:1704-1707.
25. Fan W., et al. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385:165-168.
26. Fan W., et al. The central melanocortin system can directly regulate serum insulin levels. Endocrinology 2000, 141:3072-3079.
27. Farooqi I.S., et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003, 348:1160-1163.
28. Farooqi I.S., et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000, 106(2):271-279.
29. Fekete C., et al. Alpha-melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraven-tricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci 2000, 20(4):1550-1558.
30. Fong T.M., et al. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem Biophys Res Commun 1997, 237:629-631.
31. Foster A.C., et al. MC4 receptor antagonists: A potential treatment for cachexia. IDrugs 2005, 8:311-319.
32. Gantz I., et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 1993, 268:8246-8250.
33. Gantz I., et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 1993, 268:15174-15179.
34. Graham M., et al. Overexpression of Agrt leads to obesity in transgenic mice. Nature Genetics 1997, 17:273-274.
35. Hagan H.M., et al. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol Regul Integr Comp Physiol 2000, 279(1):R47-R52.
36. Hakansson M.L., Hulting A.L., Meister B. Expression of leptin receptor mRNA in the hypothalamic arcuate nucleus-relationship with NPY neurones. Neuroreport 1996, 7(18):3087-3092.
37. Haqq A.M., et al. Characterization of a novel binding partner of the melanocortin-4 receptor: Attractin-like protein. Biochem J 2003, 376(pt 3):595-605.
38. Harris M., et al. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest 2001, 107:111-120.
39. Haskell-Luevano C., et al. Characterization of the neuroana-tomical distribution of agouti-related protein (AGRP) immuno-reactivity in the rhesus monkey and the rat. Endocrinology 1999, 140:1408-14015.
40. Haskell-Luevano C., et al. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: Identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochemistry 2001, 40(20):6164-6179.
41. Haynes W.G., et al. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999, 33(1 Pt 2):542-547.
42. Heisler L.K., et al. Activation of central melanocortin pathways by fenfluramine. Science 2002, 297(5581):609-611.
43. Hentges S.T., et al. GABA release from POMC neurons. J Neurosci 2004, 24:1578-1583.
44. Hewson A.K., Dickson S.L. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol 2000, 12:1047-1049.
45. Horvath T.L., S.Diano, Van Den Pol A.N. Synaptic inter action between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations. J Neurosci 1999, 19:1072-1087.
46. Huang X.F., et al. Localization of leptin receptor mRNA expression in mouse brain. Neuroreport 1996, 7(15-17):2635-2638.
47. Huszar D., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
48. Ibrahim N., et al. Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels. Endocrinology 2003, 144(4):1331-1340.
49. Jacobowitz D.M., O'Donohue T.L. α-Melanocyte-stimulating hormone: Immunohistochemical identification and mapping in neurons of rat brain. Proc Natl Acad Sci USA 1978, 75:6300-6344.
50. Joseph S.A., Michael G.J. Efferent ACTH-IR opiocortin projections from nucleus tractus solitarius: A hypothalamic deafferentiation study. Peptides 1988, 9:193-201.
51. Kamegai J, et al. Central effect of ghrelin, an endogenous growth hormone sccretagogue, on hypothalamic peptide gene expression. Endocrinology 2000, 141:4797-4800.
52. Kelly M.J., Qiu J., Ronnekleiv O.K. Estrogen modulation of G-protein-coupled receptor activation of potassium, channels in the centrla nervous system. Ann NY Acad Sci 2003, 1007:6-16.
53. Kiefer L.L., et al. Melanocortin receptor binding determinants in the agouti protein. Biochemistry 1998, 37(4):991-997.
54. Kim M.S., et al. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effects of leptin. J Clin Invest 2000, 105:1005-1011.
55. Kim M.S., et al. Sustained orexigenic effect of Agouti related protein may be not mediated by the melanocortin 4 receptor. Peptides 2002, 23(6):1069-1076.
56. Klebig M.L., et al. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci USA 1995, 92:4728-4732.
57. Kojima M., et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
58. Kojima M., et al. Ghrelin: Discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001, 12:118-122.
59. Konda Y., et al. Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J Biol Chem 1994, 269(18):13162-13166.
60. Krude H., et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genetics 1998, 19:155-157.
61. Leanos-Miranda A., Janovick J.A., Conn P.M. Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonad-otropic hypogonadism. J Clin Endocrinol Metab 2002, 87(10):4825-4828.
62. Legradi G., Lechan R.M. Agouti-related protein containing nerve terminals innervate thyrotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology 1999, 140(8):3643-3652.
63. Lu D., et al. Agouti protein is an antagonist of the melanocyte-stimulating, hormone receptor. Nature 1994, 371:799-802.
64. Lu X.Y., et al. Interaction between alpha-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses. J Neurosci 2003, 23(21):7863-7872.
65. Lu X.Y., et al. Time course of short-term and long-term orexigenic effects of Agouti-related protein (86-132). Neuroreport 2001, 12(6):1281-1284.
66. Marsh D.J., et al. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nature Genetics 1999, 21:119-122.
67. Mayer J. Regulation of energy intake and body weight: The glucostatic theory and the lipostatic hypothesis. Ann NY Acad Sci 1955, 63:15-43.
68. McMinn J.E., et al. Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-fos induction, and neuropeptide expression. Am J Physiol Regul Integr Comp Physiol 2000, 279(2):R695-R703.
69. Minokoshi Y., et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428(6982):569-574.
70. Mizuno T.M., Mobbs C.V. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 1999, 140(2):814-817.
71. Mizuno T.M., et al. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and corrected in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 1998, 47:294-297.
72. Morello J.P., Bichet D.G. Nephrogenic diabetes insipidus. Annu Rev Physiol 2001, 63:607-630.
73. Morgan K., Obici S., Rossetti L. Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J Biol Chem 2004, 279(30):31139-31148.
74. Mountjoy K.G., et al. The cloning of a family of genes that encode the melanocortin receptors. Science 1992, 257:543-546.
75. Mountjoy K.G., et al. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonoic control circuits in the brain. Mol Endocrinol 1994, 8:1298-12308.
76. Mountjoy K.G., et al. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells. Physiol Genomics 2001, 5(1):11-19.
77. Nakazato M., et al. A role for ghrelin in the central regulation of feeding. Nature 2001, 409:194-198.
78. Nilaver G., et al. Adrenocorticotropin and beta-lipotropin in the hypothalamus. Localization in the same arcuate neurons by sequential immunocytochemical procedures. J Cell Biol 1979, 81:50-58.
79. Obici S., et al. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 2002, 51(2):271-275.
80. Obici S., et al. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002, 8(12):1376-1382.
81. Obici S., et al. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 2003, 9(6):756-761.
82. Ollmann M.M., et al. Antogonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997, 278:135-147.
83. Pilcher W.H., Joseph S.A. Differential sensitivity of hypothalamic and medullary opiocortin and tyrosine hydroxylase neurons to the neurotoxic effects of monosodium glutamate (MSG). Peptides 1986, 7(5):783-789.
84. Roseberry A.G., et al. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 2004, 41(5):711-722.
85. Roselli-Rehfuss L., et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic systems. Proc Natl Acad Sci USA 1993, 90:8856-8860.
86. Rosenfeld R.D., et al. Biochemical, biophysical, and pharmacological characterization of bacterially expressed human agouti-related protein. Biochemistry 1998, 37:16041-16052.
87. Sabatier N., et al. Alpha-melanocyte-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis. J Neurosci 2003, 23(32):10351-10358.
88. Sarkar S., Legradi G., Lechan R.M. Intracerebroventricular administration of alpha-melanocyte stimulating hormone increases phosphorylation of CREB in TRH-and CRH-producting neurons of the hypothalamic paraventricular nucelus. Brain Res 2002, 945(1):50-59.
89. Schwartz M.W., et al. Leptin increases hypothalamic proopiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997, 46:2119-21123.
90. Shintani M., et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001, 50:227-232.
91. Shinyama H., et al. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 2003, 144(4):1301-1314.
92. Shutter J.R., et al. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 1997, 11(5):593-602.
93. + channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 2000, 3(8):757-758.
94. Srinivasan S., et al. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J Clin Invest 2004, 114(8):1158-1164.
95. Stephens T., et al. The role of neuropeptide Y in the antiobesity action of the obesity gene product. Nature 1995, 377:530-532.
96. Takahashi K.A., Cone R.D. Fasting induces a large, leptin-dependent increase in the intrinsic action potential frequency of orexigenic arcuate nucleus neuropeptide Y /Agouti-related protein neurons. Endocrinology 2005, 146(3):1043-1047.
97. Tamura H., et al. Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats. Endocrinology 2002, 143(9):3268-3275.
98. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407:908-913.
99. Tschop M., et al. GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein. Endocrinology 2002, 143(2):558-568.
100. Tshop M., et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001, 24(6):RC19-RC21.
101. Vaisse C., et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nature Genetics 1998, 20:113-114.
102. Vaisse C., et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000.
103. VanLeeuwen D., et al. Cell surface expression of the melanocortin-4 receptor is dependent on a C-terminal di-isoleucine sequence at codons 316/317. J Biol Chem 2003, 278(18):15935-15940.
104. Wang L., Saint-Pierre D.H., Tache Y. Peripheral ghrelin selectively increases fos expression in neuropeptide Y-synthe-sizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett 2002, 325(1):47-51.
105. Watson S.J., et al. Evidence for two separate opiate peptide neuronal systems and the coexistence of beta-lipotropin, betaendorphin, and ACTH immunoreactivities in the same hypo-thalamic neurons. Nature 1978, 226-228.
106. Willard D.H., et al. Agouti structure and function: Characterization of a potent α-melanocyte stimulating hormone receptor antagonist. Biochemistry 1995, 34:12341-12346.
107. Willesen M., Kristensen, Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 1999, 70:306-316.
108. Williams D.L., et al. Behavioral processes underlying the intake suppressive effects of melanocortin 3/4 receptor activation in the rat. Psychopharmacology (Berl) 2002, 161(1):47-53.
109. Yang Y.K., et al. Characterization of Agouti-related protein binding to melanocortin receptors. Mol Endocrinol 1999, 13(1):148-155.
110. Yaswen L., et al. Obesity in the mouse model of pro-opi-omelanocortin deficiency responds to peripheral melanocortin. Nat Med 1999, 5(9):1066-1070.
111. Yen T.T., et al. Obesity, diabetes, and neoplasia in yellow A(vy)/-mice ectopic expression of the agouti gene. FASEB J 1994, 8(8):479-488.
112. Yeo G.S.H., et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nature Genetics 1998, 20:111-112.
113. Yeo G.S., et al. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet 2003, 12(5):561-574.